In AD, TSPO is upregulated to reduce neurodegeneration as AD progresses by elevating neuroprotective steroid synthesis, reducing β-amyloid toxicity and decreasing oxidative stress [74]. This evidence concerns the gene TSPO and Alzheimer disease.